Cargando…
Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling
BACKGROUND: Recent studies have reported improved diastolic function in patients administered sodium-glucose cotransporter 2 inhibitors (SGLT2i). We aimed to investigate the effect of dapagliflozin on left ventricular (LV) diastolic function in a diabetic animal model and to determine the molecular...
Autores principales: | Lee, Seul-Gee, Kim, Darae, Lee, Jung-Jae, Lee, Hyun-Ju, Moon, Ro-kyung, Lee, Yong-Joon, Lee, Seung-Jun, Lee, Oh-Hyun, Kim, Choongki, Oh, Jaewon, Lee, Chan Joo, Lee, Yong-ho, Park, Seil, Jeon, Ok-Hee, Choi, Donghoon, Hong, Geu-Ru, Kim, Jung-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450279/ https://www.ncbi.nlm.nih.gov/pubmed/36068525 http://dx.doi.org/10.1186/s12916-022-02485-z |
Ejemplares similares
-
Anti-Inflammatory Effect for Atherosclerosis Progression by Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitor in a Normoglycemic Rabbit Model
por: Lee, Seul-Gee, et al.
Publicado: (2020) -
A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects
por: Kim, Hyun Chul, et al.
Publicado: (2023) -
Macrophage polarization and acceleration of atherosclerotic plaques in a swine model
por: Lee, Seul-Gee, et al.
Publicado: (2018) -
Synergistic protective effects of a statin and an angiotensin receptor blocker for initiation and progression of atherosclerosis
por: Lee, Seul-Gee, et al.
Publicado: (2019) -
Metallic Foreign Body in Heart Mimicking Moderator Band
por: Kim, Darae, et al.
Publicado: (2015)